Minerva Neurosciences Statistics

Total Valuation

NERV has a market cap or net worth of $12.73 million. The enterprise value is $46.20 million.

Market Cap	12.73M
Enterprise Value	46.20M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

NERV has 6.99 million shares outstanding. The number of shares has increased by 27.34% in one year.

Current Share Class	6.99M
Shares Outstanding	6.99M
Shares Change (YoY)	+27.34%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	4.02%
Owned by Institutions (%)	30.12%
Float	5.44M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	-0.59
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 6.23

Current Ratio	6.23
Quick Ratio	5.92
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-3.63

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-28.91%
Return on Invested Capital (ROIC)	-31.21%
Return on Capital Employed (ROCE)	-63.92%
Revenue Per Employee	n/a
Profits Per Employee	-$367,950
Employee Count	9
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -79.32% in the last 52 weeks. The beta is 0.11, so NERV's price volatility has been lower than the market average.

Beta (5Y)	0.11
52-Week Price Change	-79.32%
50-Day Moving Average	2.20
200-Day Moving Average	2.60
Relative Strength Index (RSI)	34.70
Average Volume (20 Days)	77,136

Short Selling Information

The latest short interest is 20,897, so 0.30% of the outstanding shares have been sold short.

Short Interest	20,897
Short Previous Month	19,882
Short % of Shares Out	0.30%
Short % of Float	0.38%
Short Ratio (days to cover)	0.39

Income Statement

Revenue	n/a
Gross Profit	-12.40M
Operating Income	-24.50M
Pretax Income	-33.65M
Net Income	-3.31M
EBITDA	-24.49M
EBIT	-24.50M
Earnings Per Share (EPS)	-$0.44

Full Income Statement

Balance Sheet

The company has $26.53 million in cash and $60.00 million in debt, giving a net cash position of -$33.47 million or -$4.79 per share.

Cash & Cash Equivalents	26.53M
Total Debt	60.00M
Net Cash	-33.47M
Net Cash Per Share	-$4.79
Equity (Book Value)	-21.67M
Book Value Per Share	-3.10
Working Capital	23.45M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-20.38M
Capital Expenditures	n/a
Free Cash Flow	-20.38M
FCF Per Share	-$2.91

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NERV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-27.34%
Shareholder Yield	-27.34%
Earnings Yield	-26.02%
FCF Yield	-160.08%

Analyst Forecast

The average price target for NERV is $5.00, which is 174.73% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	174.73%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on June 21, 2022. It was a reverse split with a ratio of 0.125:1.

Last Split Date	Jun 21, 2022
Split Type	Reverse
Split Ratio	0.125:1

Scores

Altman Z-Score	n/a
Piotroski F-Score	1